Provider review
Vaylen review
Every figure is written per month, and the footnote calls each one a year bought at once.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
From $83.25 sema, $149 tirz — each a 12-month prepay divided by 12
Visit VaylenThe site says monthly plans exist and prices none of them, so the plan a cautious reader would actually choose has no published figure.
Price as published
Vaylen
From $83.25 sema, $149 tirz — each a 12-month prepay divided by 12
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Vaylen prices well and publishes clearly, and a reader who skims will still come away with the wrong number in their head. The figures sit in the largest type on the page with a per-month suffix on each, and the dagger governing them is one line of small print saying each is the per-month cost of a twelve-month program billed upfront. That is a year of medication bought in a single charge. Divided by twelve it produces an attractive number; paid as advertised it is a substantial commitment made before a clinician has confirmed the treatment suits you. The refund promise takes some sting out of that — a full refund is stated if a clinician declines to prescribe — but it covers being turned down, not starting and stopping. The more useful sentence for anyone testing a small dose is the one immediately after: shorter programs and monthly plans are available. Those are exactly the plans a cautious reader wants, and not one of them carries a price anywhere on the site. So the pricing is precise about the option such a reader is least likely to choose and silent about the one they are most likely to choose. Nothing attaches a dose to any figure either, so even the annual arithmetic cannot be checked against an amount of drug. The medication, the prescription and the check-ins are stated to be inside the price rather than billed alongside it, and a needle-free daily tablet is sold beside the injectables.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You have already decided to commit for a year and want the lowest annual figure
- You want a needle-free daily tablet as an option rather than injections only
- You want a stated refund if a clinician decides the treatment is not appropriate
Look elsewhere if
- You want to pay by the month. Those plans are said to exist and none of them is priced
- You are testing a small dose before committing. Every published figure assumes a year
- You want to check a figure against an amount of drug. No dose is attached to any of them
What it actually costs
Price as published
From $83.25 sema, $149 tirz — each a 12-month prepay divided by 12
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Every per-month figure on the page is defined by the site's own footnote as the per-month cost of a twelve-month program billed upfront — a year bought in one charge and divided by twelve, not a rate anyone can pay monthly. The same footnote says monthly plans exist and prices none of them, so the plan a reader testing a low dose would actually buy has no published figure. No low-dose product is offered and no dose is attached to any figure. A needle-free daily tablet is sold alongside the injectables, which is a more forgiving vehicle for a small dose than drawing a partial unit.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Optional
- Pricing
- Check plan terms
What it does well
- The footnote defines the pricing honestly instead of leaving the term implied.
- The stated plan includes the medication, the prescription, check-ins and shipping.
- A full refund is promised if a clinician decides treatment is not appropriate.
Pharmacy, labs and oversight
Vaylen does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Vaylen publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Vaylen prices well and publishes clearly, and a reader who skims will still come away with the wrong number in their head. The figures are set in the largest type on the page with a per-month suffix on each one, and the dagger that governs them is a single line of small print under the grid saying that each is the per-month cost of a twelve-month program billed upfront. That is a year of medication bought in one charge. Divided by twelve it produces an attractive number; paid as advertised it is a four-figure commitment made before a clinician has confirmed the treatment suits you. The company's refund promise takes some of the sting out of that — it says plainly that a full refund follows if a clinician declines to prescribe — but the refund covers the case where you are turned down, not the case where you start and stop. For this site's reader the more useful sentence is the one that follows: shorter programs and monthly plans are available. Those are the plans a person testing a low dose would actually want, and not one of them carries a price anywhere on the site. So the published pricing is precise about the option a cautious reader is least likely to choose and silent about the one they are most likely to choose. Nothing on the page attaches a dose to any figure either, so even the annual arithmetic cannot be checked against an amount of drug. Clinical services are stated to run through OpenLoop Health, and the medication, the prescription and the check-ins are stated to be inside the price rather than billed alongside it.
The honest cons
Every headline figure is a year bought in one charge, divided by twelve.
- The monthly plans the page says exist are not priced anywhere on the site.
- No dose is attached to any figure, so none of it can be checked against a quantity.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Vaylen is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Vaylen does. Both are partners: we may earn a commission if you start care through these links.
Partner
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
Standard plan, self-directed low dose
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Where this sits
#226 of 548
Ordered with the companies that pay us first, and Vaylen is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
$249/mo month to month ($199 on 6-mo)
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by Belmar · Strive · Epiq Scripts · Casa Pharma Rx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.